Nian Nian Yi Yang secures tens of millions in angel funding to build quantifiable aging platform
Guangzhou Nian Nian Yi Yang Technology Service Co., Ltd. (hereinafter referred to as "Nian Nian Yi Yang Technology") has recently completed a tens of millions angel funding round. This round was exclusively led by Qielou Investment, a firm focused on life sciences investments.
It is reported that the raised funds will be primarily used to advance the research and development of several cutting-edge testing projects centered around the "Three-Tier Precision Model," support brand promotion, cross-disciplinary team building, and accelerate the commercialization and channel expansion of precision health management services.
Against the backdrop of an era where aging is gradually shifting from passive acceptance to being quantified and intervened, Nian Nian Yi Yang Technology positions itself not merely as a provider of single testing services, but is committed to creating a comprehensive "personal aging baseline" for each user. To this end, based on its three-tier precision health model—"Genetic Base," "Physiological Status," and "Health Trends"—the company aims to build a comprehensive, scientifically-grounded system for delaying aging that allows for active intervention.
Guided by the product philosophy of "Understandable Science, Manageable Youth," Nian Nian Yi Yang Technology has launched its BioLogue advanced testing product series, designed to help users achieve a profound dialogue with their own bodies.
The series' inaugural product, "Shiguang," is a physiological age test based on DNA methylation. Due to its stability and strong predictive performance, DNA methylation is widely used in physiological aging assessment research and is recognized as a single biomarker with high reference value. This product serves as a key component within Nian Nian Yi Yang Technology's Three-Tier Precision Health Model, aiming to provide users with a scientific and precise foundation for initiating their quantified anti-aging journey.
Nian Nian Yi Yang Technology offers far more than just a report; it provides a complete, closed-loop precision health management service encompassing "Scientific Testing - Recommended Plan - Implementation & Intervention - Tracking & Optimization." Based on the testing data, the company delivers personalized, actionable intervention plans. Through regular follow-up testing, it uses data to document changes and trends to demonstrate effectiveness, allowing users to visually see positive improvements in their health metrics.
With the infusion of this funding round, Nian Nian Yi Yang Technology's strategic layout is poised for a comprehensive upgrade: evolving from providing precision testing services towards building an open platform ecosystem, actively constructing the infrastructure for longevity technology. Specifically, the company will collaborate with more global research partners to advance the discovery of aging biomarkers and the development of intervention solutions, continuously infusing innovation into the industry. Concurrently, using precision testing as the core lever, it will work with industry partners to translate cutting-edge scientific achievements into actionable solutions for delaying aging.